1. Home
  2. CHMI vs KPTI Comparison

CHMI vs KPTI Comparison

Compare CHMI & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHMI
  • KPTI
  • Stock Information
  • Founded
  • CHMI 2012
  • KPTI 2008
  • Country
  • CHMI United States
  • KPTI United States
  • Employees
  • CHMI N/A
  • KPTI 325
  • Industry
  • CHMI Real Estate Investment Trusts
  • KPTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHMI Real Estate
  • KPTI Health Care
  • Exchange
  • CHMI Nasdaq
  • KPTI Nasdaq
  • Market Cap
  • CHMI 92.0M
  • KPTI 81.1M
  • IPO Year
  • CHMI 2013
  • KPTI 2013
  • Fundamental
  • Price
  • CHMI $3.49
  • KPTI $0.66
  • Analyst Decision
  • CHMI Buy
  • KPTI Strong Buy
  • Analyst Count
  • CHMI 3
  • KPTI 4
  • Target Price
  • CHMI $5.00
  • KPTI $5.00
  • AVG Volume (30 Days)
  • CHMI 270.7K
  • KPTI 671.2K
  • Earning Date
  • CHMI 03-06-2025
  • KPTI 02-27-2025
  • Dividend Yield
  • CHMI 17.19%
  • KPTI N/A
  • EPS Growth
  • CHMI N/A
  • KPTI N/A
  • EPS
  • CHMI N/A
  • KPTI N/A
  • Revenue
  • CHMI N/A
  • KPTI $148,442,000.00
  • Revenue This Year
  • CHMI N/A
  • KPTI $5.47
  • Revenue Next Year
  • CHMI $27.78
  • KPTI $6.33
  • P/E Ratio
  • CHMI N/A
  • KPTI N/A
  • Revenue Growth
  • CHMI N/A
  • KPTI 1.77
  • 52 Week Low
  • CHMI $2.50
  • KPTI $0.58
  • 52 Week High
  • CHMI $3.99
  • KPTI $1.70
  • Technical
  • Relative Strength Index (RSI)
  • CHMI 80.03
  • KPTI 46.51
  • Support Level
  • CHMI $3.07
  • KPTI $0.60
  • Resistance Level
  • CHMI $3.33
  • KPTI $0.70
  • Average True Range (ATR)
  • CHMI 0.09
  • KPTI 0.05
  • MACD
  • CHMI 0.04
  • KPTI -0.00
  • Stochastic Oscillator
  • CHMI 94.92
  • KPTI 46.61

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

Share on Social Networks: